The University of Virginia Medical Center has standardized technology in its operating rooms, obstetric, and surgical intensive care units with Masimo Technology.
The facility now uses Masimo Radical-7 Pulse CO-Oximeters with noninvasive hemoglobin (SpHb) and Masimo Acoustic Respiration Rate (RRa) to perform noninvasive and continuous monitoring of hemoglobin blood levels and respiration rate, respectively.
“We use the Radical-7 with SpHb primarily for complex spine cases, where we have a particular need to track hemoglobin levels on a continuous basis,” said Marcel Durieux, MD, of UVA Medical Center’s Department of Anesthesiology. “Having a trending measure rather than having to rely only on intermittent blood gas measurement is helpful, and it allows us to better time when to get a blood gas.”
The RRa has been clinically shown to reduce risky and unnecessary blood transfusions while dramatically reducing costs, according to the manufacturer. Because SpHb monitoring provides real-time directional trends in hemoglobin – such as indicating stable hemoglobin when it may be perceived to be dropping, and rising hemoglobin when it may be perceived to not be rising fast enough – it can help clinicians initiate necessary transfusions faster.
“UVA Medical Center enjoys a well-earned reputation for providing quality patient care,” said Joe Kiani, CEO and founder of Masimo. “We at Masimo are honored to have been a partner with UVA for many years, and we’re committed to continuing to provide the advanced, high-quality medical technology this leading healthcare organization needs to help further improve patient outcomes and reduce costs.”